KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Times Interest Earned: 2011-2024

Historic Times Interest Earned for Esperion Therapeutics (ESPR) over the last 14 years, with Dec 2024 value amounting to $0.92.

  • Esperion Therapeutics' Times Interest Earned rose 57.50% to -$0.45 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.37, marking a year-over-year decrease of 231.85%. This contributed to the annual value of $0.92 for FY2024, which is 134.81% up from last year.
  • Per Esperion Therapeutics' latest filing, its Times Interest Earned stood at $0.92 for FY2024, which was up 134.81% from -$2.64 recorded in FY2023.
  • In the past 5 years, Esperion Therapeutics' Times Interest Earned registered a high of $0.92 during FY2024, and its lowest value of -$5.35 during FY2020.
  • Over the past 3 years, Esperion Therapeutics' median Times Interest Earned value was -$2.64 (recorded in 2023), while the average stood at -$1.63.
  • Data for Esperion Therapeutics' Times Interest Earned shows a peak YoY soared of 134.81% (in 2024) over the last 5 years.
  • Esperion Therapeutics' Times Interest Earned (Yearly) stood at -$5.35 in 2020, then grew by 8.66% to -$4.89 in 2021, then spiked by 35.40% to -$3.16 in 2022, then climbed by 16.52% to -$2.64 in 2023, then spiked by 134.81% to $0.92 in 2024.